← Back to Search

NAVA Ventilation for Congenital Heart Disease

N/A
Recruiting
Led By Guillaume Emeriaud, Dr
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights

Study Summary

This trialstudies how NAVA ventilation impacts brain and body hemodynamics in post-op cardiac surgery patients. It will compare NAVA to conventional ventilation over two periods and measure changes in heart, brain and lung function.

Eligible Conditions
  • Congenital Heart Defects
  • Single Ventricle Heart
  • Tetralogy of Fallot
  • Hypoplastic Left Heart Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain oxygen extraction
Brain oxygenation
Brain perfusion
Secondary outcome measures
Brain regional oxygen consumption
Cardiac index
Cardiac output
+7 more
Other outcome measures
Patient comfort

Trial Design

2Treatment groups
Experimental Treatment
Group I: Neurally adjusted ventilatory assist firstExperimental Treatment1 Intervention
Ventilation in NAVA mode then ventilation in conventional mode
Group II: Conventional ventilation firstExperimental Treatment1 Intervention
Ventilation in conventional mode then ventilation in NAVA mode

Find a Location

Who is running the clinical trial?

St. Justine's HospitalLead Sponsor
196 Previous Clinical Trials
78,999 Total Patients Enrolled
Guillaume Emeriaud, DrPrincipal InvestigatorSt. Justine's Hospital

Media Library

Neurally adjusted ventilatory assist first Clinical Trial Eligibility Overview. Trial Name: NCT04581668 — N/A
Congenital Heart Defects Research Study Groups: Neurally adjusted ventilatory assist first, Conventional ventilation first
Congenital Heart Defects Clinical Trial 2023: Neurally adjusted ventilatory assist first Highlights & Side Effects. Trial Name: NCT04581668 — N/A
Neurally adjusted ventilatory assist first 2023 Treatment Timeline for Medical Study. Trial Name: NCT04581668 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025